Cardiogenic shock in general intensive care unit: a nationwide prospective analysis of epidemiology and outcome

Tavazzi Guido1,2, Tricella Giovanni3, Garbero Elena3

  • 1Department of Clinical-Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Viale Golgi 19, 27100 Pavia, Italy.

Insights

Cardiogenic shock (CS) in general ICUs is primarily caused by left heart failure, with right heart failure-CS posing the highest mortality risk. Multiorgan failure and delayed ICU admission worsen outcomes for these critical patients.

Area of Science:

  • Critical Care Medicine
  • Cardiology
  • Epidemiology

Background:

  • Cardiogenic shock (CS) carries a high mortality risk (up to 50%), with evolving epidemiology favoring non-ischaemic causes.
  • Existing data often derive from specialized cardiac care units, necessitating research in general intensive care units (ICUs).

Purpose of the Study:

  • To investigate the epidemiology and outcomes of patients with CS admitted to general ICUs.
  • To identify factors associated with mortality in this patient population.

Main Methods:

  • Prospective, multicenter epidemiological study involving 314 general ICUs from 2011 to 2018.
  • Included 11,052 patients with CS (excluding cardiac arrest), analyzing mortality and associated clinical factors using logistic regression.

Main Results:

  • The overall ICU mortality for CS was 44.8%, rising to 54.3% by the latest hospital follow-up.
  • Left heart failure was the most common etiology (47.5%), while right heart failure-CS (RHF-CS) showed the highest mortality risk.
  • Multiorgan insufficiency, respiratory failure, coagulation disorders, renal dysfunction, severe hypotension, older age, and longer pre-ICU hospital stay were associated with increased mortality.

Conclusions:

  • In general ICUs, left heart failure remains the predominant CS etiology, with RHF-CS associated with significantly higher mortality.
  • Multiorgan failure upon admission and prolonged hospital stay before ICU admission are critical predictors of adverse outcomes in CS patients.
Abstract